Edition:
United States

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

10.85CNY
26 May 2017
Change (% chg)

¥-0.18 (-1.63%)
Prev Close
¥11.03
Open
¥11.03
Day's High
¥11.07
Day's Low
¥10.79
Volume
6,153,972
Avg. Vol
6,327,388
52-wk High
¥15.08
52-wk Low
¥10.64

600267.SS

Chart for 600267.SS

About

Zhejiang Hisun Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products. The Company's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infec... (more)

Overall

Beta: 1.14
Market Cap(Mil.): ¥10,495.33
Shares Outstanding(Mil.): 965.53
Dividend: 0.05
Yield (%): 0.64

Financials

  600267.SS Industry Sector
P/E (TTM): -- 14.27 17.41
EPS (TTM): -0.10 -- --
ROI: 0.80 -7.17 -5.42
ROE: -1.37 -6.63 -4.68

BRIEF-Zhejiang Hisun Pharmaceutical receives administrative order

* Says it received an administrative order from Zhejiang Regulatory Bureau of China Securities Regulatory Commission, regarding information disclosure and false financial report

Apr 25 2017

BRIEF-Zhejiang Hisun Pharmaceutical amends FY 2016 net profit outlook

* Says in the previous outlook, the company expected the net profit for FY 2016 to increase by 260 percent to 300 percent

Mar 29 2017

BRIEF-Zhejiang Hisun Pharmaceutical gets approval for three drugs to enter clinical trials

* Says it got approval from China Food and Drug Administration to do clinical trials for three kinds of crud drugs

Mar 16 2017

BRIEF-Zhejiang Hisun Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice(GMP) certificate from Zhejiang Food and Drug Administration

Mar 15 2017

BRIEF-Zhejiang Hisun Pharmaceutical sees FY 2016 net profit up 260 pct to 300 pct

* Sees net profit for FY 2016 to increase by 260 percent to 300 percent

Jan 25 2017

BRIEF-Zhejiang Hisun Pharmaceutical appoints Guan Xuhua as CFO

Dec 17 Zhejiang Hisun Pharmaceutical Co Ltd : * Says it appoints Guan Xuhua as CFO to replace Hu Liangbin Source text in Chinese: https://goo.gl/aWixl4 Further company Coverage: (Beijing Headline News)

Dec 17 2016

More From Around the Web

Earnings vs. Estimates